Featured News

The Celiac Disease Foundation is proud to recognize our dedicated volunteers, Francie Wallack and Josh Denney.

The Celiac Disease Foundation is in discussion with a team at the University of Colorado, Denver to develop the first-ever, FDA-approved pediatric PRO (patient-reported outcome tool).

To share with you some insight into our advocacy work, I recently interviewed Mark Van de Water, Senior Advisor at Baker Donelson.

A few highlights from research studies published in peer-reviewed journals in the last few months are products of the research grants CDF awarded.

Anokion SA announced successful completion of its Phase 1 clinical trial evaluating KAN-101 for the treatment of celiac disease, with promising results.

researchers concluded that patients with celiac disease who are infected with COVID-19 are not at higher risk of hospitalization.

I am pleased to share a research grant awarded to the Dubcovsky Lab at UC Davis for Development of a Novel Dietary Treatment for Celiac Disease that may significantly reduce the suffering experienced by our patient community.

ZED1227, an experimental drug was found to be able to prevent intestinal damage in a preliminary trial of 163 adults with celiac disease.

The Celiac Disease Foundation achieved a number of critical milestones in 2020 in our efforts to accelerate the development of treatments and a cure for celiac disease.

The Celiac Disease Foundation is proud to partner with Mediaplanet for their Morning Nutrition campaign.